ALSS -- Artificial Liver Support System

Name: ALSS
ITEM NO.: DX-10
Origin: China
MOQ: 1 PCS
Brand: DAYBREAK
On Sale: June, 2005 -- Now
Standard: International Standard
Certified: Ministry of Health Department (China)
Application by Department:
ICU, Nephrology, Neurology, Obstetrics, Gastroenterology, Hematology, Epidemiology
Rheumatology, Dermatology, Otolaryngology, Cardiovascular, Ophthalmology, etc.

Abstract:
...Automatic Plasma Exchanged, Plasma Adsorption, Blood Corpuscle Purification
...Automatic Continuous Renal Replacement Therapy (CRRT)
...Automatic Continuous Blood Purification (CBP)
...Continuous Plasma Filtration Adsorption (CPFA) --- NEW Function
...PE, DFPP, PA, PP, HP, DHP, HF, CVVHF, CWHDF, SCUF, ECUM, DFPP, DHP, LCAP..
Except for HD, suitable for all kind blood purification applications
...Already widely used in main hospitals in China
Very easy to use, simple system to control, can be updated new system
10.4 inch color touch screen, automatic inductor keep machine safety
Contain 10 main cure methods, also, some expansion slots enable to DIY & load new cure method at anytime.

We will offer the training program for the buyers, more details, please contacu us info@ballya.biz

Artificial Liver Support System is an important method for curing the hepatic failure. It processes the blood and plasma of the severe hepatopath by using the blood cleansing technology, Through treatment, it is able to clear away the poisonous substances like endotoxin, bilirubin etc while supplying various blood coagulation factors and immunoglobulin in the plasma to alleviate the patient's symptoms and improve the blood coagulation mechanism. Artificial Liver Support System can replace part of the metabolism, detoxication and synthesis functions of the liver temporarily, thus providing necessary extrinsic function supports for the severely pathologic changed livers to help the patient to pull through the critical stage and gain precious time for the further clinical treatment (like the liver transplantation etc.)

Blood Purification has been applied conventionally as an artificial kidney or artificial liver in the management of patients with multiple organ failure (MOF), and most blood purifications have been performed intermittently. Recent advances in medical engineering made it possible to perform such blood purifications continuously (i.e., 24 hours a day, 7 days a week if necessary) even in critically ill patients. This modality is referred to as continuous renal replacement therapy (CRRT) or continuous blood purification (CBP). Among many kinds of CBP, continuous hemodiafiltration (CHDF) is most useful for management of MOF, as it can be performed without serious or hazardous side effects, and improvement can be expected with it. Recently, CHDF and polymyxin B immobilized endotoxin adsorption columns were used for the prevention or treatment of MOF, with the expectation that such therapy can be effective as a countermeasure against the pathophysiologic causes of MOF. Our data and that of others clearly indicate that continuous blood purification, such as with CHDF and endotoxin adsorption, can remove or decrease the blood levels of humoral mediators, including proinflammatory cytokines, and can improve tissue oxygenation, especially oxygen consumption (VO2) among critically ill patients including those with MOF. Blood purification is also useful in the careful management of fluid, electrolytes, and acid-base balance and for the removal of metabolic wastes. Blood purification is now considered to be one of the basic therapeutic tools of critical care, equal to nutritional support with total parenteral nutrition and respiratory support without a ventilator.




Technical Datas of DX-10